Breeze Holdings Acquisition Corp. Announces Definitive Agreement to Merge with YD Biopharma Limited
September 25, 2024 07:30 ET
|
Breeze Holdings Acquisition Corp.
YD Biopharma is a Clinical-Stage Biopharmaceutical Company Focusing on Cancer Prevention Diagnostics and Seeking to Transform the Treatment of a Wide Spectrum of Diseases Pro Forma for the...
Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
September 25, 2024 07:30 ET
|
Acasti Pharma, Inc.
PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of...
LuxUrban Hotels to Host Webcast to Review the Financial Results for the Second Quarter of 2024
September 25, 2024 07:30 ET
|
LuxUrban Hotels Inc.
LuxUrban Hotels to Host Webcast to Review the Financial Results for the Second Quarter of 2024
Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024
September 25, 2024 07:30 ET
|
Ocular Therapeutix, Inc.
BEDFORD, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to improving vision in the real world...
23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating
September 25, 2024 07:30 ET
|
23andMe, Inc.
SUNNYVALE, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co., (Nasdaq: ME), a leading human genetics and preventive health company, today released a new report on the genetics of...
Amedisys has earned the 2023 SHPBest™ Patient Satisfaction Awards
September 25, 2024 07:30 ET
|
Amedisys, Inc.
BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, has 92 home health and hospice care...
InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 European Academy of Dermatology and Venereology Congress
September 25, 2024 07:30 ET
|
InflaRx N.V.
JENA, Germany, Sept. 25, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced...
New Breakthrough Could Revolutionize Online Video and Gaming Experiences
September 25, 2024 07:24 ET
|
Adeia Inc.
"Selective Enablement of L4S Transport for Latency-Sensitive Multimedia Delivery” has been accepted for presentation at the IEEE MMSP show.
Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress
September 25, 2024 07:08 ET
|
Oruka Therapeutics, Inc.
Half-life in non-human primates (NHP) of 30.3 days after subcutaneous (SQ) administration and 33.8 days after intravenous (IV) administration Equivalent potency to risankizumab with similar binding...
Eightco Announces $100 million Revenue Forecast – Releases 2025 Strategic Plan
September 25, 2024 07:00 ET
|
Eightco Holdings Inc.
Improved Financial Condition Allows Focus on Revenue Growth & Profitability Easton, PA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ: OCTO) (the “Company” or “Eightco”)...